For Jill, the issue isn’t whether life has value. It is what kind of life is being preserved. If she can no longer eat without choking, recognize loved ones, or share what she wants, would inserting a ...

One thing that helps columnist Tanita Allen ease fear about future symptoms is separating what she can do today from what she ...

Columnist Tanita Allen's mindfulness and meditation practice has taught her that she doesn't need to fight herself every ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google My wife, Jill, who is gene-positive with Huntington’s disease (HD ...

Differences in brain connections for people who carry a mutation known to cause Huntington’s disease are detectable decades before the onset of motor symptoms, a study showed. The findings suggested ...

A global clinical trial testing SKY-0515, Skyhawk Therapeutics’ daily oral therapy for Huntington’s disease, will soon start recruiting adults with the genetic condition in the U.S., Canada, and the U ...

uniQure has submitted an application to the U.S. Food and Drug Administration (FDA) seeking accelerated approval of AMT-130, the Netherlands-based company’s gene therapy candidate for Huntington’s ...

A single injection of Wave Life Science‘s experimental therapy WVE-003 was found, at either of the two lowest tested doses, to lead to reductions in the mutant huntingtin (mHTT) protein in people with ...

Several late-stage clinical trials are now recruiting participants to test whether three experimental oral therapies can slow the progression of Huntington’s disease, with active or planned sites in ...

The first participant has been dosed in a large clinical trial testing the experimental oral therapy votoplam (formerly PTC518) in adults with early-stage Huntington’s disease. The Novartis-sponsored ...

“Can they tell by looking at me how useless and weak and flimsy and [artificial] (and how foney) I feel?” — notes from Woody Guthrie, dated Aug. 21, 1952 Woody Guthrie was an American ...

Latus Bio plans to submit an application with the U.S. Food and Drug Administration (FDA) to move LTS-201, a one-time gene therapy for Huntington’s disease, into clinical trials. The application, ...